James Shapiro

1.1k total citations
28 papers, 780 citations indexed

About

James Shapiro is a scholar working on Surgery, Hepatology and Genetics. According to data from OpenAlex, James Shapiro has authored 28 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 9 papers in Hepatology and 7 papers in Genetics. Recurrent topics in James Shapiro's work include Pancreatic function and diabetes (14 papers), Organ Transplantation Techniques and Outcomes (9 papers) and Liver Disease and Transplantation (7 papers). James Shapiro is often cited by papers focused on Pancreatic function and diabetes (14 papers), Organ Transplantation Techniques and Outcomes (9 papers) and Liver Disease and Transplantation (7 papers). James Shapiro collaborates with scholars based in Canada, United States and United Kingdom. James Shapiro's co-authors include Tatsuya Kin, Norman M. Kneteman, Klaus S. Gutfreund, Vincent G. Bain, Edmond A. Ryan, Jonathan R.T. Lakey, Mang Ma, Praveen Elamanchili, John Samuel and Afsaneh Lavasanifar and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Diabetes.

In The Last Decade

James Shapiro

26 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Shapiro Canada 16 470 284 173 141 138 28 780
Norman Kneteman Canada 13 412 0.9× 184 0.6× 90 0.5× 102 0.7× 101 0.7× 24 725
S Hayashi Japan 13 255 0.5× 50 0.2× 51 0.3× 30 0.2× 155 1.1× 70 544
Andrew L. Lobashevsky United States 17 416 0.9× 53 0.2× 151 0.9× 33 0.2× 90 0.7× 41 869
AJ Demetris United States 14 385 0.8× 269 0.9× 195 1.1× 18 0.1× 44 0.3× 27 733
G Ramadori Germany 13 172 0.4× 323 1.1× 247 1.4× 14 0.1× 18 0.1× 44 666
Lisa Moberg Sweden 8 861 1.8× 26 0.1× 30 0.2× 351 2.5× 474 3.4× 9 999
Shinichiro Yokota United States 13 196 0.4× 151 0.5× 148 0.9× 5 0.0× 59 0.4× 33 582
T Hamashima Japan 13 222 0.5× 42 0.1× 56 0.3× 13 0.1× 23 0.2× 52 604
J Peña United Kingdom 6 367 0.8× 216 0.8× 103 0.6× 9 0.1× 55 0.4× 10 779
Yuji Nishio Japan 14 191 0.4× 21 0.1× 118 0.7× 13 0.1× 164 1.2× 38 528

Countries citing papers authored by James Shapiro

Since Specialization
Citations

This map shows the geographic impact of James Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Shapiro more than expected).

Fields of papers citing papers by James Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Shapiro. The network helps show where James Shapiro may publish in the future.

Co-authorship network of co-authors of James Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of James Shapiro. A scholar is included among the top collaborators of James Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Shapiro. James Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapiro, James & Denis Noble. (2021). The value of treating cancer as an evolutionary disease. Progress in Biophysics and Molecular Biology. 165. 1–2. 5 indexed citations
2.
Raza, Muhammad Haseeb, Whitney E. Jackson, Angela Dell, et al.. (2020). Health-related quality of life after anonymous nondirected living liver donation: A multicenter collaboration. American Journal of Transplantation. 21(3). 1056–1067. 9 indexed citations
3.
Lam, Anna, et al.. (2020). 1093. Infectious Complications after Pancreatic Islet Transplantation. Open Forum Infectious Diseases. 7(Supplement_1). S576–S576. 2 indexed citations
4.
Emamaullee, Juliet, Susan Kim, Reginald Tucker‐Seeley, et al.. (2020). Living donor financial assistance programs in liver transplantation: The global perspective. Clinical Transplantation. 34(11). e14073–e14073. 10 indexed citations
5.
6.
Andrès, Axel, Aldo J. Montaño‐Loza, Russell Greiner, et al.. (2018). A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis. PLoS ONE. 13(3). e0193523–e0193523. 29 indexed citations
7.
Halpin, Anne, Luis Hidalgo, James Shapiro, et al.. (2017). Patient Tailored Crossmatch, Do Islet Cell and Pancreas Transplants Call for a Different Fit?. Transplantation. 101(5S-3). S29–S29. 1 indexed citations
8.
Lee, Seung Hee, Ergeng Hao, James Shapiro, et al.. (2011). The Id3/E47 Axis Mediates Cell-Cycle Control in Human Pancreatic Ducts and Adenocarcinoma. Molecular Cancer Research. 9(6). 782–790. 21 indexed citations
9.
Gur, Chamutal, Jonatan Enk, Judith Magenheim, et al.. (2011). Recognition and Killing of Human and Murine Pancreatic β Cells by the NK Receptor NKp46. The Journal of Immunology. 187(6). 3096–3103. 54 indexed citations
10.
Kin, Tatsuya & James Shapiro. (2010). Surgical aspects of human islet isolation. Islets. 2(5). 265–273. 33 indexed citations
11.
Molinari, Michele, Kenneth Berman, Glenda Meeberg, et al.. (2009). Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients. Transplant International. 23(2). 155–168. 25 indexed citations
12.
Haddadi, Azita, et al.. (2007). Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. Journal of Biomedical Materials Research Part A. 84A(4). 885–898. 72 indexed citations
13.
Miao, Gang, John Mace, Michael A. Kirby, et al.. (2006). In Vitro and In Vivo Improvement of Islet Survival Following Treatment with Nerve Growth Factor. Transplantation. 81(4). 519–524. 36 indexed citations
14.
O’Gorman, Doug, Tatsuya Kin, Travis B. Murdoch, et al.. (2005). The Standardization of Pancreatic Donors for Islet Isolations. Transplantation. 80(6). 801–806. 66 indexed citations
15.
Ramji, Alnoor, Eric M. Yoshida, Vincent G. Bain, et al.. (2002). Late acute rejection after liver transplantation: The Western Canada experience. Liver Transplantation. 8(10). 945–951. 34 indexed citations
16.
Shapiro, James, Edmond A. Ryan, Ray V. Rajotte, et al.. (2002). Improved function of islet grafts under steroid-free immunosuppression: will grafts work forever? Response to letter by Birkeland et al.. Transplantation. 73(9). 1528–1528.
17.
Ryan, Edmond A., Jonathan R.T. Lakey, & James Shapiro. (2001). Clinical Results after Islet Transplantation. Journal of Investigative Medicine. 49(6_suppl). 559–562. 14 indexed citations
18.
Álvarez, Fernando, Paul Atkison, David Grant, et al.. (2000). NOF-11: A ONE-YEAR PEDIATRIC RANDOMIZED DOUBLE-BLIND COMPARISON OF NEORAL VERSUS SANDIMMUNE IN ORTHOTOPIC LIVER TRANSPLANTATION 1. Transplantation. 69(1). 87–87. 11 indexed citations
19.
Egawa, Hiroto, Mureo Kasahara, Yukihiro Inomata, et al.. (1999). LONG-TERM OUTCOME OF LIVING RELATED LIVER TRANSPLANTATION FOR PATIENTS WITH INTRAPULMONARY SHUNTING AND STRATEGY FOR COMPLICATIONS1,2. Transplantation. 67(5). 712–717. 101 indexed citations
20.
Bain, Vincent G., Norman M. Kneteman, Mang Ma, et al.. (1996). EFFICACY OF LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ACTIVE VIRAL REPLICATION AND DECOMPENSATED CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION1. Transplantation. 62(10). 1456–1462. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norman Kneteman Breakdown of academic impact, for papers by S Hayashi Breakdown of academic impact, for papers by Andrew L. Lobashevsky Breakdown of academic impact, for papers by AJ Demetris Breakdown of academic impact, for papers by G Ramadori Breakdown of academic impact, for papers by Lisa Moberg Breakdown of academic impact, for papers by Shinichiro Yokota Breakdown of academic impact, for papers by T Hamashima Breakdown of academic impact, for papers by J Peña Breakdown of academic impact, for papers by Yuji Nishio
Rankless by CCL
2026